1. Home
  2. LPL vs IOVA Comparison

LPL vs IOVA Comparison

Compare LPL & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPL
  • IOVA
  • Stock Information
  • Founded
  • LPL 1985
  • IOVA 2007
  • Country
  • LPL South Korea
  • IOVA United States
  • Employees
  • LPL N/A
  • IOVA N/A
  • Industry
  • LPL Industrial Machinery/Components
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LPL Technology
  • IOVA Health Care
  • Exchange
  • LPL Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • LPL 3.2B
  • IOVA 2.6B
  • IPO Year
  • LPL 2004
  • IOVA N/A
  • Fundamental
  • Price
  • LPL $3.15
  • IOVA $7.26
  • Analyst Decision
  • LPL Sell
  • IOVA Strong Buy
  • Analyst Count
  • LPL 2
  • IOVA 9
  • Target Price
  • LPL N/A
  • IOVA $23.33
  • AVG Volume (30 Days)
  • LPL 173.7K
  • IOVA 5.1M
  • Earning Date
  • LPL 01-22-2025
  • IOVA 11-07-2024
  • Dividend Yield
  • LPL N/A
  • IOVA N/A
  • EPS Growth
  • LPL N/A
  • IOVA N/A
  • EPS
  • LPL N/A
  • IOVA N/A
  • Revenue
  • LPL $19,931,616,429.00
  • IOVA $90,858,000.00
  • Revenue This Year
  • LPL $25.60
  • IOVA $13,758.71
  • Revenue Next Year
  • LPL $0.35
  • IOVA $171.64
  • P/E Ratio
  • LPL N/A
  • IOVA N/A
  • Revenue Growth
  • LPL 23.27
  • IOVA 12751.20
  • 52 Week Low
  • LPL $3.10
  • IOVA $6.70
  • 52 Week High
  • LPL $5.66
  • IOVA $18.33
  • Technical
  • Relative Strength Index (RSI)
  • LPL 38.50
  • IOVA 30.16
  • Support Level
  • LPL $3.28
  • IOVA $7.69
  • Resistance Level
  • LPL $3.26
  • IOVA $8.14
  • Average True Range (ATR)
  • LPL 0.06
  • IOVA 0.41
  • MACD
  • LPL 0.00
  • IOVA -0.10
  • Stochastic Oscillator
  • LPL 29.97
  • IOVA 8.12

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in a number of countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: